Celaid Therapeutics
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $10M
Investors
- 5
About Celaid Therapeutics
Based in Tokyo, Japan, and founded in 2020, Celaid Therapeutics Inc. operates as a biotechnology research company that engages in the research and development of regenerative medicine and products using human hematopoietic stem cells. In October 2025, Celaid Therapeutics Inc. The company is working on the development of cell therapies for intractable blood diseases including blood/hematologic cancers such as leukemia and genetic diseases, by using the proliferation of hematopoietic stem cells in umbilical cord blood and peripheral blood. The company uses its platform technology of in vitro expansion of functional hematopoietic stem cells, without choosing its origins, including bone marrow, cord blood, or peripheral blood.
Who invested in Celaid Therapeutics
5 investors across 3 rounds
See all investors in Celaid Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celaid Therapeutics
Who invested in Celaid Therapeutics?
Celaid Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celaid Therapeutics raised?
Celaid Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Celaid Therapeutics last raise money?
Celaid Therapeutics's most recent round on record is a Series B, in Oct 2025.
What does Celaid Therapeutics do?
Based in Tokyo, Japan, and founded in 2020, Celaid Therapeutics Inc.
Where is Celaid Therapeutics headquartered?
Celaid Therapeutics is headquartered in Tokyo, Japan.
Which VCs invest in companies like Celaid Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Celaid Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Celaid Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.